Logo image of DCBO.CA

DOCEBO INC (DCBO.CA) Stock Fundamental Analysis

TSX:DCBO - Toronto Stock Exchange - CA25609L1058 - Common Stock - Currency: CAD

39.12  -0.35 (-0.89%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to DCBO. DCBO was compared to 62 industry peers in the Software industry. While DCBO has a great health rating, its profitability is only average at the moment. DCBO is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, DCBO could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year DCBO was profitable.
In the past year DCBO had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DCBO reported negative net income in multiple years.
Of the past 5 years DCBO 4 years had a positive operating cash flow.
DCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFDCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

The Return On Assets of DCBO (11.66%) is better than 87.10% of its industry peers.
DCBO has a Return On Equity of 43.94%. This is amongst the best in the industry. DCBO outperforms 91.94% of its industry peers.
With an excellent Return On Invested Capital value of 21.50%, DCBO belongs to the best of the industry, outperforming 93.55% of the companies in the same industry.
Industry RankSector Rank
ROA 11.66%
ROE 43.94%
ROIC 21.5%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO.CA Yearly ROA, ROE, ROICDCBO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

DCBO has a Profit Margin of 10.34%. This is amongst the best in the industry. DCBO outperforms 82.26% of its industry peers.
DCBO's Operating Margin of 9.40% is fine compared to the rest of the industry. DCBO outperforms 75.81% of its industry peers.
DCBO's Gross Margin of 80.94% is amongst the best of the industry. DCBO outperforms 90.32% of its industry peers.
DCBO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.4%
PM (TTM) 10.34%
GM 80.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO.CA Yearly Profit, Operating, Gross MarginsDCBO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DCBO is creating value.
Compared to 1 year ago, DCBO has about the same amount of shares outstanding.
DCBO has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DCBO has an improved debt to assets ratio.
DCBO.CA Yearly Shares OutstandingDCBO.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO.CA Yearly Total Debt VS Total AssetsDCBO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 3.68 indicates that DCBO is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.68, DCBO is doing good in the industry, outperforming 64.52% of the companies in the same industry.
DCBO has a debt to FCF ratio of 0.04. This is a very positive value and a sign of high solvency as it would only need 0.04 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.04, DCBO belongs to the top of the industry, outperforming 93.55% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that DCBO is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.00, DCBO belongs to the best of the industry, outperforming 85.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Altman-Z 3.68
ROIC/WACC2.74
WACC7.85%
DCBO.CA Yearly LT Debt VS Equity VS FCFDCBO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.15 indicates that DCBO should not have too much problems paying its short term obligations.
DCBO has a Current ratio of 1.15. This is comparable to the rest of the industry: DCBO outperforms 48.39% of its industry peers.
DCBO has a Quick Ratio of 1.15. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
DCBO has a Quick ratio of 1.15. This is comparable to the rest of the industry: DCBO outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
DCBO.CA Yearly Current Assets VS Current LiabilitesDCBO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 336.36% over the past year.
DCBO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.79%.
Measured over the past years, DCBO shows a very strong growth in Revenue. The Revenue has been growing by 39.25% on average per year.
EPS 1Y (TTM)336.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.82%
Revenue 1Y (TTM)16.79%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%11.46%

3.2 Future

The Earnings Per Share is expected to grow by 27.76% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 24.94% on average over the next years. This is a very strong growth
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue Next Year11.76%
Revenue Next 2Y12.58%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DCBO.CA Yearly Revenue VS EstimatesDCBO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO.CA Yearly EPS VS EstimatesDCBO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.86, which means the current valuation is very expensive for DCBO.
Based on the Price/Earnings ratio, DCBO is valued a bit cheaper than 77.42% of the companies in the same industry.
DCBO's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.28.
Based on the Price/Forward Earnings ratio of 19.82, the valuation of DCBO can be described as rather expensive.
80.65% of the companies in the same industry are more expensive than DCBO, based on the Price/Forward Earnings ratio.
DCBO is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 29.86
Fwd PE 19.82
DCBO.CA Price Earnings VS Forward Price EarningsDCBO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

DCBO's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 70.97% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 31.05
EV/EBITDA 31.6
DCBO.CA Per share dataDCBO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

DCBO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DCBO has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as DCBO's earnings are expected to grow with 21.71% in the coming years.
PEG (NY)0.76
PEG (5Y)N/A
EPS Next 2Y29.84%
EPS Next 3Y21.71%

0

5. Dividend

5.1 Amount

DCBO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

TSX:DCBO (7/2/2025, 7:00:00 PM)

39.12

-0.35 (-0.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners36.86%
Inst Owner ChangeN/A
Ins Owners1.46%
Ins Owner ChangeN/A
Market Cap1.16B
Analysts78.57
Price Target40.09 (2.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.55%
Min EPS beat(2)26.05%
Max EPS beat(2)91.05%
EPS beat(4)3
Avg EPS beat(4)25.39%
Min EPS beat(4)-25.3%
Max EPS beat(4)91.05%
EPS beat(8)6
Avg EPS beat(8)-11.33%
EPS beat(12)10
Avg EPS beat(12)140.75%
EPS beat(16)12
Avg EPS beat(16)97.01%
Revenue beat(2)0
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)-0.51%
Revenue beat(4)1
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)0.37%
Revenue beat(8)1
Avg Revenue beat(8)-0.7%
Revenue beat(12)1
Avg Revenue beat(12)-1.11%
Revenue beat(16)3
Avg Revenue beat(16)-0.47%
PT rev (1m)-17.97%
PT rev (3m)-19.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.41%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.31%
Valuation
Industry RankSector Rank
PE 29.86
Fwd PE 19.82
P/S 3.82
P/FCF 31.05
P/OCF 29.6
P/B 16.24
P/tB 23.1
EV/EBITDA 31.6
EPS(TTM)1.31
EY3.35%
EPS(NY)1.97
Fwd EY5.04%
FCF(TTM)1.26
FCFY3.22%
OCF(TTM)1.32
OCFY3.38%
SpS10.24
BVpS2.41
TBVpS1.69
PEG (NY)0.76
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.66%
ROE 43.94%
ROCE 36.68%
ROIC 21.5%
ROICexc N/A
ROICexgc N/A
OM 9.4%
PM (TTM) 10.34%
GM 80.94%
FCFM 12.31%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score8
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Debt/EBITDA 0
Cap/Depr 39.83%
Cap/Sales 0.6%
Interest Coverage 250
Cash Conversion 118.32%
Profit Quality 119.04%
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z 3.68
F-Score8
WACC7.85%
ROIC/WACC2.74
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)336.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.82%
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue 1Y (TTM)16.79%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%11.46%
Revenue Next Year11.76%
Revenue Next 2Y12.58%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%
EBIT growth 1Y347.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year120.45%
EBIT Next 3Y50.2%
EBIT Next 5Y32.1%
FCF growth 1Y2197.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1283.74%
OCF growth 3YN/A
OCF growth 5YN/A